Advancing Care for Patients Receiving CAR T-Cell Therapy: New Evidence and Opportunities for Oncology Pharmacy Practice

Download this slideset from a local live webinar to learn how to optimally manage your patients with hematologic malignancies using CAR T-cell therapy.
Craig Freyer, PharmD, BCOP
Andrew Lin, PharmD, BCOP
Format: Microsoft PowerPoint (.ppt)
File Size: 829 KB
Released: April 1, 2022

Acknowledgements

Provided by ProCE, LLC in partnership with Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bristol-Myers Squibb

Related Content

Expert-selected slides on chronic lymphocytic leukemia with a pharmacy perspective to help treat your patients with CLL, from ProCE and Clinical Care Options (CCO).

Lydia Benitez, PharmD, BCOP Caitlin R. Rausch, PharmD Released: May 18, 2022

In slides from Clinical Care Options (CCO), expert pharmacists provide insights on the use of novel systemic therapies for HCC

Courtney C. Cavalieri, PharmD, BCOP Amber Draper, PharmD, BCOP Released: May 18, 2022

Rebecca Gonzalez, PharmD, BCOP, discusses key pharmacy strategies for management of patients with multiple myeloma in this commentary from Clinical Care Options (CCO)

Rebecca Gonzalez, PharmD, BCOP Released: May 6, 2022

Experts discuss current and emerging oral targeted therapies in early and advanced HR+/HER2- breast cancer, from Clinical Care Options (CCO)

Allison Butts, PharmD, BCOP Kristina F. Byers, PharmD, BCOP Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 3, 2022 Expired: May 2, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings